Reckitt’s Health business may have declined in Q4 but recorded mid-single-digit sales growth for the full year, giving management belief it can deliver the goods in 2024.
Addressing analysts on the UK-based firm’s 28 February earnings call, CFO Jeff Carr described the 2% drop in like-for-like Health
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?